Schulte, R.; Wohlleber, D.; Unrau, L.; Geers, B.; Metzger, C.; Erhardt, A.; Tiegs, G.; van Rooijen, N.; Heukamp, L.C.; Klotz, L.;
et al. Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis. Int. J. Mol. Sci. 2020, 21, 2523.
https://doi.org/10.3390/ijms21072523
AMA Style
Schulte R, Wohlleber D, Unrau L, Geers B, Metzger C, Erhardt A, Tiegs G, van Rooijen N, Heukamp LC, Klotz L,
et al. Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis. International Journal of Molecular Sciences. 2020; 21(7):2523.
https://doi.org/10.3390/ijms21072523
Chicago/Turabian Style
Schulte, Rike, Dirk Wohlleber, Ludmilla Unrau, Bernd Geers, Christina Metzger, Annette Erhardt, Gisa Tiegs, Nico van Rooijen, Lukas C. Heukamp, Luisa Klotz,
and et al. 2020. "Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis" International Journal of Molecular Sciences 21, no. 7: 2523.
https://doi.org/10.3390/ijms21072523
APA Style
Schulte, R., Wohlleber, D., Unrau, L., Geers, B., Metzger, C., Erhardt, A., Tiegs, G., van Rooijen, N., Heukamp, L. C., Klotz, L., Knolle, P. A., & Diehl, L.
(2020). Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis. International Journal of Molecular Sciences, 21(7), 2523.
https://doi.org/10.3390/ijms21072523
